Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alabama for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alabama only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alabama (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ali Hachem (NPI 1437117157)

Field	Value
Entity Type	Individual
Organization	Ali Hachem
Address	3601 Cci Dr Nw
City	Huntsville
State	AL
ZIP	35805
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 2, 2006

Payer Source	Total Paid
Medicare	$2.3M
Medicaid	$0

Key Findings

ALI HACHEM is a Hematology & Oncology Physician in HUNTSVILLE, AL with an NPI enumerated 2006-05-02 (~20 years ago). The provider reports $2.3M in total Medicare revenue and has no Medicaid billing on file, making the practice effectively single-payer from a public program perspective and heavily exposed to Medicare beneficiary volume and reimbursement patterns.

Revenue concentration is very high: the precomputed top 3 Medicare codes account for 80.1% of this provider's total Medicare revenue. Those three codes are J9271 ($1.2M, 53.3%), J9299 ($374.9K, 16.5%), and J0897 ($235.4K, 10.3%), indicating most Medicare dollars flow from a small set of high-cost injectable therapies.

The procedure mix is consistent with an infusion-based oncology practice focused on immune checkpoint inhibitors and bone-targeted therapy: J9271 and J9299 are pembrolizumab and nivolumab infusions, while J0897 (denosumab) targets bone-related complications. Supporting codes — including chemotherapy administration codes such as 96413, G0498, 96365 and add-on infusion codes like 96417/96415 — reinforce that the operation delivers office/clinic-based parenteral oncology treatments and follow-up infusion care.

Competitive standing for the top injectable drugs is mixed but generally above median national activity: J9271 is ranked #149 of 1841 providers (92th percentile; typical, unremarkable volume for this code), J9299 is #205 of 505 providers (60th percentile; typical, unremarkable volume), and J0897 is #701 of 10057 providers (93th percentile; typical, unremarkable volume). In plain terms, the provider posts robust national-level activity for these agents but does not appear to be an outlier leader in pembrolizumab or nivolumab beyond common specialty patterns.

Billing patterns show unusually high intensity for high-complexity office visits: 99215 has 763 claims and generated $96.1K (4.2% of Medicare revenue) and is ranked #622 of 145531 providers (100th percentile; extreme outlier, far above typical national volume for this code). 99214 also appears at elevated national percentiles (918 claims, $78.9K, 3.5%; rank #14156 of 479517, 97th percentile; notably above typical national volume), suggesting frequent high-level evaluation-and-management encounters and complex outpatient management.

Inpatient and observation care are also part of the service mix: subsequent and initial inpatient E/M codes (99233, 99232, 99223) appear among top codes, indicating the provider bills for hospital-based visits in addition to clinic infusions. This mix of high-level outpatient E/M plus inpatient E/M implies the provider manages both ambulatory oncology and hospital follow-up or consults.

Operational intensity for supportive diagnostics and routine monitoring is high: lab panels and CBCs (80053, 85025) and phlebotomy (36415) appear in the top code list with 1.6K–1.9K claims and sit at 97th–98th national percentiles, while chemotherapy administration codes such as 96413 (546 claims, $48.6K; 93th percentile) are notably above typical national volume. These patterns are consistent with a practice that combines frequent day-of-infusion monitoring and on-site lab services to support systemic cancer therapy.

Payer mix and business implications: with $2.3M in Medicare revenue and no Medicaid billing on file, the practice is reliant on Medicare beneficiaries and associated reimbursement schedules. That concentration reduces exposure to Medicaid but raises sensitivity to Medicare policy changes affecting high-cost oncology injectables and infusion reimbursement.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

43 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	28,200	$40	$1.2M
J9299	Injection, nivolumab, 1 mg	17,040	$20	$374.9K
J0897	Injection, denosumab, 1 mg	13,080	$20	$235.4K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	760	$130	$96.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	920	$90	$78.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	550	$90	$48.6K
99233	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the…	520	$90	$45.6K
99223	The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the…	140	$130	$18K
99232	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or…	310	$60	$18K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	1,610	$10	$16.1K

Showing 1–10 of 43

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 43 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alabama Distribution

Ali Hachem — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alabama

Full comparison — all codes billed, vs. state median

43 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	6	30	19,900	$40	$827.2K
J9299	5	10	19,060	$20	$535.1K
J0897	20	200	3,120	$20	$97.7K
J0881	24	30	7,720	$1	$24.1K
J9217	35	50	130	$130	$22.4K
96413	15	150	150	$90	$20.2K
99214	218	7,330	120	$80	$16.8K
99233	90	1,860	80	$90	$13.4K
99232	510	2,530	100	$60	$13.3K
80053	34	670	140	$10	$13.1K

Showing 1–10 of 43

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ali Hachem, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
John Waples	AL	Medical Oncology Physician	$9.6M	$0
Marshall Schreeder	AL	Medical Oncology Physician	$3.5M	$0
Heather Brody	AL	Hematology & Oncology Physician	$3.1M	$0
Jorge Diaz	AL	Hematology & Oncology Physician	$2.6M	$0
Naveen Lobo	AL	Medical Oncology Physician	$2.4M	$0
Daniel Schreeder	AL	Hematology & Oncology Physician	$2.3M	$0
Brian Heller	AL	Hematology & Oncology Physician	$2.3M	$0
Robert Conry	AL	Hematology & Oncology Physician	$2.1M	$0
Lakshmikanth Katragadda	AL	Hematology & Oncology Physician	$2.1M	$0
Oncology Specialties, P.C.	AL	Hematology & Oncology Physician	$0	$2M

Nearby Providers

Other providers in the same ZIP code as Ali Hachem, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Huntsville Emergency Medical Services, Inc.	AL	Land Ambulance	$5.6M	$6M
Madison Core Laboratories, LLC	AL	Clinical Medical Laboratory	$1.5M	$4M
Hc Healthcare, LLC	AL	Community Based Hospice Care Agency	$0	$4.8M
The Village Medical Clinic	AL	Specialist	$0	$2M
Ehab El-bahesh	AL	Hematology & Oncology Physician	$1.7M	$0
Pathology Associates, P.C.	AL	Anatomic Pathology & Clinical Pathology Physician	$0	$1.7M
Rehabilitation & Neurological Services LLC	AL	Specialist	$0	$1.3M
Philip Mcgee	AL	Hematology & Oncology Physician	$1.2M	$0
John Nicholson	AL	Hematology & Oncology Physician	$1.2M	$0
Elizabeth Falkenberg	AL	Radiation Oncology Physician	$1.1M	$0

Ali Hachem — Billing Profile & Reimbursement Data

Sign up for Ali Hachem — Billing Profile & Reimbursement Data policy alerts

Ali Hachem — Billing Profile & Reimbursement Data

Sign up for Ali Hachem — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References